Return Rates of Non-invasive Forms of Colorectal Cancer Screening in a Central California Community Health Center.
Journal of the National Hispanic Medical Association · 03.06.2025 · 3 (1)
DOI: 10.59867/001c.136833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the National Hispanic Medical Association, online erschienen am 03.06.2025. Verfasst von Marsha R Cheng und 2 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Colorectal cancer (CRC) screening is pivotal for early detection and improved outcomes, yet underserved populations face significant barriers to achieving screening goals. While colonoscopy remains the gold standard, non-invasive options such as the Fecal Immunochemical Test (FIT) annually and multitargeted stool DNA (mt-sDNA) every three years are increasingly viable, especially in underserved communities with decreased access to colonoscopies.
Purpose
This study evaluates the efficacy of FIT versus mt-sDNA in a Federally Qualified Health Center (FQHC) in Central California, focusing on return rates as a proxy for screening adherence.
Methods
A retrospective analysis was performed on over 1000 patients due for colorectal cancer screening between 2022-2023 and had a FIT or mt-sDNA test ordered individually during a visit, or via bulk order. We analyzed the return rates after at minimum 60 days from time of ordering CRC screening. Chi-square test of independence was utilized with multiple test correction via Bonferroni for p-values to demonstrate statistical significance between the different groups.
Results
FIT had a return rate of 25.8%, with 7% encountering collection or processing issues. In contrast, mt-sDNA ordered in bulk yielded a return rate of 13.2%, while mt-sDNA ordered individually by provider after a visit showed a higher return rate of 46.7%. Statistical analysis demonstrated significant differences in return rates between FIT and mt-sDNA under both ordering conditions (p < 0.05).
Conclusion
These findings suggest that mt-sDNA, valid for three years compared to FIT’s one-year validity, may enhance long-term adherence to CRC screening guidelines. The study underscores the impact of ordering strategy on screening effectiveness, particularly in FQHC settings. It highlights the potential of mt-sDNA, especially when ordered during a visit, to improve CRC screening rates compared to FIT.
Zitieren
APA
Cheng, M. R., Warren, E. B., & Ayala-Rodriguez, I. (2025). Return Rates of Non-invasive Forms of Colorectal Cancer Screening in a Central California Community Health Center. Journal of the National Hispanic Medical Association, 3(1). https://doi.org/10.59867/001c.136833
Vancouver
Cheng MR, Warren EB, Ayala-Rodriguez I. Return Rates of Non-invasive Forms of Colorectal Cancer Screening in a Central California Community Health Center. Journal of the National Hispanic Medical Association. 2025;3(1). doi:10.59867/001c.136833
BibTeX
@article{Cheng2025,
author = {Cheng, Marsha R and Warren, Emily B and Ayala-Rodriguez, Irving},
title = {Return Rates of Non-invasive Forms of Colorectal Cancer Screening in a Central California Community Health Center},
journal = {Journal of the National Hispanic Medical Association},
year = {2025},
volume = {3},
number = {1},
doi = {10.59867/001c.136833}
}
EUVIMED